DRUGMAX COM INC
10QSB/A, EX-27, 2000-06-20
HEALTH SERVICES
Previous: DRUGMAX COM INC, 10QSB/A, EX-2.3, 2000-06-20
Next: PHOTOELECTRON CORP, 8-K, 2000-06-20



<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information extracted from the financial
statements and is qualified in its entirety by reference to such
financialstatements.
</LEGEND>

 <S>                          <C>
<PERIOD-TYPE>                 3-MOS
<FISCAL-YEAR-END>                         MAR-31-1999
<PERIOD-END>                              DEC-31-1999
<CASH>                                    8,200,631
<SECURITIES>                              0
<RECEIVABLES>                             5,381,128
<ALLOWANCES>                              27,222
<INVENTORY>                               1,291,968
<CURRENT-ASSETS>                          15,108,965
<PP&E>                                    107,958
<DEPRECIATION>                            17,820
<TOTAL-ASSETS>                            36,922,756
<CURRENT-LIABILITIES>                     5,717,328
<BONDS>                                   0
                     0
                               0
<COMMON>                                  6,077
<OTHER-SE>                                31,199,351
<TOTAL-LIABILITY-AND-EQUITY>              36,922,756
<SALES>                                   7,170,581
<TOTAL-REVENUES>                          7,170,581
<CGS>                                     7,112,971
<TOTAL-COSTS>                             7,112,971
<OTHER-EXPENSES>                          0
<LOSS-PROVISION>                          0
<INTEREST-EXPENSE>                        32,159
<INCOME-PRETAX>                           (481,591)
<INCOME-TAX>                              0
<INCOME-CONTINUING>                       (481,591)
<DISCONTINUED>                            0
<EXTRAORDINARY>                           0
<CHANGES>                                 0
<NET-INCOME>                              (481,591)
<EPS-BASIC>                               (0.12)
<EPS-DILUTED>                             (0.12)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission